PGT-A:它是为了什么,有什么问题?
Stéphane Viville1,2, Mohamed Aboulghar3,4
1Laboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, UF3472-Génétique de L'infertilité, 67000, Strasbourg, France. stephane.viville@unistra.fr.
Journal of assisted reproduction and genetics
|January 23, 2025
概括
预植入基因测试 (PGT-A) 是为了通过选择euploid胚胎来提高试管婴儿的成功而开发的. 然而,目前的证据表明,PGT-A提供了最小的益处,甚至可能减少试管婴儿的结果,质疑其临床价值.
科学领域:
- 生殖医学 生殖医学
- 遗传学 遗传学是一种遗传学.
- 胚胎学 胚胎学
背景情况:
- 胎儿动脉增多与母亲的年龄,导致流产.
- 输卵前遗传检测 (PGT-A) 是为了通过选择胚胎来改善试管婴儿结果而引入的.
- 尽管PGT-A已经被广泛使用了近30年,但它的有效性仍然受到争议.
研究的目的:
- 评估PGT-A在辅助生殖中的临床实用性和有效性.
- 根据现有证据,批判性地评估PGT-A的好处和缺点.
- 探索围绕PGT-A实践的伦理影响.
主要方法:
- 审查研究检查PGT-A对医疗辅助生殖 (MAR) 结果的影响的研究.
- 对比胚胎移植成功率与治疗意图结果的研究分析.
- 探索与PGT-A建议相关的伦理考虑.
主要成果:
- 最初的研究表明改善了MAR结果,但使用胚胎移植作为参考.
- 最近的治疗意图分析显示,PGT-A的试管婴儿结果有限或减少.
- PGT-A的临床价值是有争议的,并没有得到一致的证明.
结论:
- 在改善试管婴儿结果方面,PGT-A的有效性并未始终被证明.
- 有证据表明,PGT-A可能提供有限的益处,并可能对试管婴儿成功率产生负面影响.
- 该研究得出的结论是,PGT-A应不再定期提供给不育夫妇.
相关概念视频
Nondisjunction
3.7K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.7K
CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K


